Publication
» Go to news mainIncidence of pancreatic cancer during long‑term follow‑up in patients with incidental pancreatic cysts smaller than 2 cm
A new publication from Dr. Mathew Bligh!
Click here to view the article.
Abstract
Purpose
To assess the long-term malignancy risk of incidental small pancreatic cysts.
Materials and methods
In this HIPAA-compliant, IRB-approved, retrospective, multi-institutional study, the long-term incidence of pancreatic cancer was compared between patients with and without small pancreatic cysts. Patients with incidental pancreatic cysts ≥ 0.5 and < 2.0 cm in maximal diameter, detected on MRI performed between 1999 and 2011, represented the “small pancreatic cyst” group. Patients that underwent MRI between 2005 and 2011 and had no reported pancreatic cysts represented the comparison “no cyst” group.
Results
The “small pancreatic cyst” group included 267 patients, ages 63.4 ± 11.8 years, 166/267 (62%) women with a mean follow-up of 8.6 ± 4.3 years, median 9.2 years; the “no cyst” group included 1,459 patients, ages 64.6 ± 12 years, 794/1,459 (54%) women with a mean follow-up of 7.0 ± 4.2 years, median 7.8 (p values 0.12, 0.02, < 0.001, respectively). Two/267 (0.7%) patients developed pancreatic cancer at a separate location from the known cyst in the “small pancreatic cyst” group, with a cancer rate of 0.9 (95% CI 0.1–3.1) cases per 1,000 patient-years. In the “no cyst” cohort, 18/1,459 (1.2%) patients developed pancreatic cancer, with a cancer rate of 1.8 (95% CI 1.2–3.1) cases per 1,000 patient-years (p = 0.6). The all-cause mortality was similar in both groups: 57/267 (21%) vs. 384/1,459 (26%) (p = 0.09).
Conclusion
The long-term risk of pancreatic malignancy in asymptomatic patients with incidental pancreatic cysts less than 2 cm is 0.9 cases per 1,000 patient-years of follow-up, similar to those without pancreatic cysts. These very few pancreatic cancers developed at a separate location from the known cyst.
Recent News
- Dr. Abraham receives CAIR Award
- Thank you to everyone who joined us for the 30th anniversary Radiology Research Day on May 8th!
- Nova Scotia’s Lung Screening Program expanding to Cape Breton, eastern mainland
- Donor‑supported nuclear medicine technology attracts top medical talent to the QEII
- Building Critical Skills at the Dalhousie Physician Leadership Workshop for Women in Radiology
- CAR/CSTR Practice Guideline on CT Screening for Lung Cancer
- CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity
- CAR Practice Guideline on Bone Mineral Densitometry Reporting: 2024 Update